Abstract
In 1971-3 data on smoking habits, cigarette brand smoked, morning phlegm production, and lung function were recorded for factory workers as part of the Heart Disease Prevention Project. These men were reassessed in 1984 and those who had always smoked cigarettes from the same tar group were compared with those who had dropped one tar group (mean decreases of 6.6 mg tar, 0.1 mg nicotine) and two tar groups (mean decreases of 11.9 mg tar, 0.5 mg nicotine). Over the 13 years, men who had dropped one tar group were significantly more likely (p less than 0.05) to stop producing phlegm, but the effect was less marked for those who had dropped two tar groups. The mean fall in FEV1 was similar in all three groups, but 95% confidence limits showed that although dropping one tar group could be associated with at most a saving of 84 ml over the follow up period, there could be little extra benefit from dropping two tar groups. In 1984, all three groups of smokers excreted similar amounts of nicotine metabolites in the urine, suggesting that men who had dropped two tar groups compensated for the reduced nicotine yield of their cigarettes. This could account for the lack of a dose response relationship between reduction in the tar yield of cigarettes and cessation of phlegm and fall in FEV1.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Beck G. J., Doyle C. A., Schachter E. N. Smoking and lung function. Am Rev Respir Dis. 1981 Feb;123(2):149–155. doi: 10.1164/arrd.1981.123.2.149. [DOI] [PubMed] [Google Scholar]
- Comstock G. W., Brownlow W. J., Stone R. W., Sartwell P. E. Cigarette smoking and changes in respiratory findings. Arch Environ Health. 1970 Jul;21(1):50–57. doi: 10.1080/00039896.1970.10667191. [DOI] [PubMed] [Google Scholar]
- Dean G., Lee P. N., Todd G. F., Wicken A. J., Sparks D. N. Factors related to respiratory and cardiovascular symptoms in the United Kingdom. J Epidemiol Community Health. 1978 Jun;32(2):86–96. doi: 10.1136/jech.32.2.86. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ellard G. A., Gammon P. T., Helmy H. S., Rees R. J. Urine tests to monitor the self-administration of dapsone by leprosy patients. Am J Trop Med Hyg. 1974 May;23(3):464–470. doi: 10.4269/ajtmh.1974.23.464. [DOI] [PubMed] [Google Scholar]
- Ferris B. G., Chen H., Puleo S., Murphy R. L. Chronic nonspecific respiratory disease in Berlin, New Hampshire, 1967 to 1973. A further follow-up study. Am Rev Respir Dis. 1976 Apr;113(4):475–485. doi: 10.1164/arrd.1976.113.4.475. [DOI] [PubMed] [Google Scholar]
- Freedman S., Fletcher C. M. Changes of smoking habits and cough in men smoking cigarettes with 30% NSM tobacco substitute. Br Med J. 1976 Jun 12;1(6023):1427–1430. doi: 10.1136/bmj.1.6023.1427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hawthorne V. M., Fry J. S. Smoking and health: the association between smoking behaviour, total mortality, and cardiorespiratory disease in west central Scotland. J Epidemiol Community Health. 1978 Dec;32(4):260–266. doi: 10.1136/jech.32.4.260. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Higenbottam T., Clark T. J., Shipley M. J., Rose G. Lung function and symptoms of cigarette smokers related to tar yield and number of cigarettes smoked. Lancet. 1980 Feb 23;1(8165):409–411. doi: 10.1016/s0140-6736(80)90955-1. [DOI] [PubMed] [Google Scholar]
- Rimington J. Phlegm and filters. Br Med J. 1972 Apr 29;2(5808):262–264. doi: 10.1136/bmj.2.5808.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rose G., Heller R. F., Pedoe H. T., Christie D. G. Heart disease prevention project: a randomised controlled trial in industry. Br Med J. 1980 Mar 15;280(6216):747–751. doi: 10.1136/bmj.280.6216.747. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schenker M. B., Samet J. M., Speizer F. E. Effect of cigarette tar content and smoking habits on respiratory symptoms in women. Am Rev Respir Dis. 1982 Jun;125(6):684–690. doi: 10.1164/arrd.1982.125.6.684. [DOI] [PubMed] [Google Scholar]